icon-folder.gif   Conference Reports for NATAP  
 
  15th International Workshop on
Clinical Pharmacology
of HIV and Hepatitis Therapy
May 19- 21, 2014, Washington, DC
Back grey_arrow_rt.gif
 
 
 
Pharmacokinetic Interaction of HCV NA5A Inhibitor MK-8742 and Ketoconazole in Healthy Subjects
 
 
  Reported by Jules Levin
 
15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, Washington DC; May 19-21, 2014
 
WW Yeh1, WL Marshall1, P Auger2, L Caro1, P Jumes1, X Huang1, D Dreyer1, H-P Feng1, D Swearingen2, S Azzam2, A Hohnstein2, C Brandquist2 and JR Butterton1 1Merck & Co., Inc., Whitehouse Station, NJ, USA; 2Celerion, Tempe, AZ, USA

Pharm1.gif

Pharm2.gif

Pharm3.gif

Pharm4.gif

Pharm5.gif

Pharm6.gif

Pharm7.gif